Advertisement

The Louisville Symposium of the American Society for Pharmacology and Experimental Therapeutics (1982)

  • Leo E. Hollister

Abstract

This international symposium was organized by William Dewey and Stig Agurell and was held four years after the Reims symposium. Two hundred scientists gathered from the United States, United Kingdom, Sweden, and France to present 59 papers covering all apsects of Cannabis: clinical, chemical, metabolic, reproductive, neuropharmacolgical, cellular, and therapeutic (1). The following important contributions were selected for publication in the present monograph and are reprinted with permission of the authors and the publisher.

Keywords

Intraocular Pressure Cannabis User Antiemetic Effect Chapter Versus Chronic Cannabis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    Agurell, S., Dewey, W.L., and Willette, R. E. (1983) The Cannabinoids: Chemical, Pharmacologic and Therapeutic Apects. Academic Press, New York.Google Scholar
  2. 1.
    Petersen, R. C. (1980) Marijuana and Health: 1980, NIDA Research monograph 31, U.S. Government Printing Office, Washington, DC.Google Scholar
  3. 2.
    Nahas, G. G. (1979) Current status of marijuana research. JAMA 242, 2775 - 2778.PubMedCrossRefGoogle Scholar
  4. 3.
    Anonymous, AMA Council on Scientific Affairs. (1981) Marijuana: its health hazards and therapeutic potentials. JAMA 246, 1823 - 1827.CrossRefGoogle Scholar
  5. 4.
    Isbell, H., Gorodetsky, C. W., Jasinski, D., Claussen, U., Spulak, F. V. and Korte, F. (1967) Effects of (-)delta-9-tetrahydrocannabinol in man. Psychopharmacology 11, 184 - 188.CrossRefGoogle Scholar
  6. 5.
    Hollister, L. E., Richards, R. K. and Gillespie, H. K. (1968) Comparison of tetrahydrocannabinol and synhexyl in man. Clin. Pharmacol. and Ther. 9, 783 - 791.Google Scholar
  7. 6.
    Dornbush, R. L., Freidman, A. F. and Fink, M. (eds.) (1976) Chronic Cannabis use. Ann. N.Y. Acad. Sci. 282, 1-430.Google Scholar
  8. 7.
    Halikas, J. A., Goodwin, D. W. and Guze, S. B. (1972) Marijuana use and psychiatric illness. Arch. Gen. Psych. 27, 162 - 165.CrossRefGoogle Scholar
  9. 8.
    Abruzzi, W. (1977) Drug-induced psychosis. Int. Addict. 121, 183 - 193.Google Scholar
  10. 9.
    Kupfer, D. J., Detre, T., Koral, J. and Fajans, P. (1973) A comment on the "amotivational syndrome" in marijuana smokers, Am. J. Psych. 130, 1319 - 1321.Google Scholar
  11. 10.
    Campbell, A. M., Thomson, J. L. G. Evans, M., and Williams, M. J. (1972) Cerebral atrophy in young cannabis smokers. Lancet 1: 743, 202 - 203.Google Scholar
  12. 11.
    Kuehnle, J., Mendelson, J. H., David, K. R. and New, R. F. J. (1977) Computed tomographic examination of heavy marijuana smokers. JAMA 237, 1231 - 1232.PubMedCrossRefGoogle Scholar
  13. 12.
    Co, B. T., Goodwin, D. W., Gado, M., Mikhael, M. and Hill, S. Y. (1977) Absence of cerebral atrophy in chronic cannabis users of computerized transaxial tomography. JAMA 237, 1229 - 1230.PubMedCrossRefGoogle Scholar
  14. 13.
    Harper, J. W., Heath, R. G. and Myers, W. (1977) Effects of cannabis sativa on ultrastructure of the synapse on monkey brain. Neurosci. Res. 3, 87 - 93.CrossRefGoogle Scholar
  15. 14.
    Hollister, L. E. and Tinklenbert, J. R. (1973) Subchronic oral doses of marijuana extract. Psychopharmacology 29, 247 - 252.CrossRefGoogle Scholar
  16. 15.
    Jones, R. and Benowitz, N. (1976) The 30-day trip: clinical studies of cannabis tolerance and dependence. In: Pharmacology of Marijuana, ( Braude, M.C. and Szara, S. eds.) Raven, New York, pp. 627 - 645.Google Scholar
  17. 16.
    Belleville, J. W., Gasser, J. C. and Miyake, T. (1976) Tolerance to the respiratory effects of marijuana in man. Pharmacol. Exper. Ther. 1997, 326 - 331.Google Scholar
  18. 17.
    Tashkin, D. R, Shapiro, B. J., Lee, Y. E. and Harper, C. E. (1976) Subacute effects of heavy marijuana smoking on pulmonary function in healthy men. N. Engl. J. Med. 294, 125 - 129.PubMedCrossRefGoogle Scholar
  19. 18.
    Vachon, I. (1976) The smoke in marijuana smoking. N. Engl. J. Med. 294, 160 - 161.PubMedCrossRefGoogle Scholar
  20. 19.
    Aronow, W. S. and Cassidy, J. (1974) Effect of marijuana and place-marijuana smoking on angina pectoris. N. Engl. J. Med. 291, 65 - 67.PubMedCrossRefGoogle Scholar
  21. 20.
    Kolodny, R. C., Masters, W. H., Kolodner, R. M. and Toro, G. (1974) Depression of plasma testosterone levels after chronic intensive marijuana use. N. Engl. J. Med. 290, 872 - 874.PubMedCrossRefGoogle Scholar
  22. 21.
    Goldstein, H., Harclerode, J. and Nyquist, S. E. (1977) Effects of chronic administration of delta-9-tetrahydrocannabinol and cannabidiol on rat testicular esterase isozymes. Life Sci. 20, 951 - 954.PubMedCrossRefGoogle Scholar
  23. 22.
    Ayalon, D. and Tsafriri, A. (1973) Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta-l-tetrahydrocannabinol. Nature 243, 470 - 471.PubMedCrossRefGoogle Scholar
  24. 22.
    Leuchtenberger, C. and Leuchtenberger, R. (1976) Correlated cytological and cytochemical studies of the effects of fresh smoke from marijuana cigarettes on growth and DNA metabolism of animal and human lung culture. In: Pharmacology of Marijuana ( Braude, M.C. and Szara, S. eds.) Raven, New York, pp. 595 - 612.Google Scholar
  25. 23.
    Zimmerman, A. M. and McClean, D. K. (1973) In: Drugs and Cell Cycle (Zimmerman, Padilla, and Cameron, eds.) Academic, New York, p. 67.Google Scholar
  26. 24.
    Stencherer, M. A., Kunysz, T. J. and Allen, M. A. (1974) Chromosome breakage in users of marijuana. Am. J. Obst. Gynecol. 118, 106 - 113.Google Scholar
  27. 25.
    Nahas, G. G., Suciv-Foca, N., Armand, J. P. and Morshima, A. (1974) Inhibition of cellular mediated immunity in marijuana smokers. Science 183, 419 - 420.PubMedCrossRefGoogle Scholar
  28. 26.
    Lau, R. J., Tubergen, D. G., Barr, Jr., M., Domino, E. F., Benowitz, W. and Jones, R. T. (1976) Phytohemagglutinin induced lymphocyte transformation in humans receiving delta-9-tetrahydrocannabinol, Science 192, 805 - 807.PubMedCrossRefGoogle Scholar
  29. 27.
    Cohen, S. and Stillman, R. C. (eds.) (1976) The Therapeutic Potential of Marijuana. Plenum, New York, p. 515. •Google Scholar
  30. 28.
    Lemberger, L. (1980) Potential therapeutic usefulness of marijuana. Ann. Rev. Pharmacol. Toxicol. 20, 151 - 172.CrossRefGoogle Scholar
  31. 29.
    Sallan, S. E., Zinberg, N. E. and Frei, E. (1975) Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N. Engl. J. Med. 293, 795 - 797.PubMedCrossRefGoogle Scholar
  32. 30.
    Lucas, Jr., V. S. and Laszlo, J. (1980) Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. DAMA 243, 1241 - 1243.CrossRefGoogle Scholar
  33. 31.
    Sallan, S. E., Cronin, C., Zelen, M. and Zinberg, N. E. (1980) Antiemetics in patients receiving chemotherapy for cancer. A randomized comparison of delta-9-tetrahydrcannabinol and prochlorperazine. N. Engl. J. Med. 302, 135 - 136.PubMedCrossRefGoogle Scholar
  34. 32.
    Frytak, S., Moertel, C. G., O'Fallon, J. R., Rubin, J., Creagar, E. T., O'Donnell, M. J., Schott, A. J. and Schwartas, N. W. (1979) Delta-9-tetrahydrocannabinol as an antiemetic in patients receiving cancer chemotherapy. A comparison with prochlorperazine and placebo. Ann. Int. Med. 91, 825 - 830.PubMedCrossRefGoogle Scholar
  35. 33.
    Chang, A. S., Shiling, D. J., Stillman, R. C., Goldberg, N. H., Seipp, C. A., Barofsky, D., Simon, R. M. and Rosenberg, S. A. (1979) Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Ann. Int. Med. 91, 819 - 824.PubMedCrossRefGoogle Scholar
  36. 34.
    Coils, B. M., Ferry., D. G. and Gray, A. J. (1980) The antiemetic activity of tetrahydrocannabinol versus metoclopramide and thiethylperazine in patients undergoing cancer chemotherapy. N. Zealand Med. J. 91, 449 - 451.Google Scholar
  37. 35.
    Orr, L. L., McKernan, J. F. and Bloome, B. (1980) Antiemetic effect of tetrahydrocannabinol: compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis, Arch. Int. Med. 140, 1431 - 1433.CrossRefGoogle Scholar
  38. 36.
    Herman, T. S., Einhorn, L. H., Jones, S. E., Nagy, C., Chester, A. B., Dean, J. C., Furnas, B., Williams, S. D., Leigh, S. A., Don, R. T. and Moon, T. E. (1979) Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N. Engl. J. Med. 300, 1295 - 1297.PubMedCrossRefGoogle Scholar
  39. 37.
    Cronin, C. M., Sallan, S. E., Gelber, R., Lucas, V. S. and Laszlo, J. (1981) Antiemetic effect of intramuscular levonantradol in patients receiving anti-cancer chemotherapy. J. Clin. Pharmacol. 21, 43S - 50S.PubMedCrossRefGoogle Scholar
  40. 38.
    Stagret, M., Bron, D., Rosencweig, M. and Kenis, Y. (1981) Clinical studies with a THC analog (BRL 4664) in the prevention of cisplatin-induced vomiting. J. Clin. Pharmacol. 21, 60S - 63S.CrossRefGoogle Scholar
  41. 39.
    Gralla, R. J., Itri, L. M., Pisko, S. E., Squillante, A. E., Kelsen, D. R, Braunn, Jr., D. W., Bordin, L. A., Braunn, T. J. and Young, C. W. (1981) Antiemetic efficacy of high-dose metoclopramine: randomized trials with placebo and prochlorperazine in patients with chemotherapy induced nausea and vomiting. N. Engl. J. Med. 303, 905 - 909.CrossRefGoogle Scholar
  42. 40.
    Strum, S. B., McDermed, J. E., Opfell, E. W. and Riech, L. P. (1982) Intravenous metoclopramide: an effective antiemetic in cancer chemotherapy. JAMA 247, 2683 - 2686.PubMedCrossRefGoogle Scholar
  43. 41.
    Hepler, R. S. and Frank, I. M. (1971) Marijuana smoking and intraocular pressure. JAMA 217, 1392.PubMedCrossRefGoogle Scholar
  44. 42.
    Cooler, R. and Gregg, J. M. (1977) Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. Southern Med. J. 70, 951 - 954.PubMedCrossRefGoogle Scholar
  45. 43.
    Green, K. (1975) Marijuana and the eye. Invest. Opthalmol. 14, 261 - 263.Google Scholar
  46. 44.
    Green, K., Wynn, H. and Bowman, K. A. (1978) A comparison of topical cannabinoids on intraocular pressure. Exper. Eye Res. 27, 239 - 246.CrossRefGoogle Scholar
  47. 45.
    West. M. E. and Lockhart, A. B. (1980) The enhanced effect of the combination of cannasol and timolol and pilocarpine in intraocular pressure. West Indian Med. J. 29, 280.Google Scholar
  48. 46.
    Tiedemann, J. S., Shields, M. P. and Weber, P. A. (1981) Effect of synthetic cannabinoids on elevated intraocular pressure. Opthalmology 88, 270 - 277.Google Scholar
  49. 47.
    Noyes, R., Brunk, S. F., Aver, D. H. and Canter, A. (1975) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin. Pharmacol. Ther. 18, 84 - 89.PubMedGoogle Scholar
  50. 48.
    Raft, D., Gregg, J.,Ghia, J. and Harris, L. (1977) Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: psychological correlates of the analgesic response. Clin. Pharmacol. Ther. 21 , 26-33.Google Scholar
  51. 49.
    Gilbert, P. E. (1981) A comparison of THC, nantradol, nabilone, and morphine in the chronic spinal dog. J. Clin. Pharmacol. 21 , 311S-319S.Google Scholar
  52. 50.
    Jain, A. K., Ryan, J. E., McMahon, F. G. and Smith, G. (1981) Evaluation of infra-muscular levonantradol in acute postoperative pain. J. Clin. Pharmacol. 21 , 3205-3265.Google Scholar
  53. 51.
    Petro, D. J. and Ellenberger, C. E. (1981) Treatment of human spasticity with delta-9-tetrahydrocannabinol. J. Clin. Pharmacol. 21 , 413S-416S.Google Scholar
  54. 52.
    Loewe, S. and Goodman, L. S. (1947) Anticonvulsive action of marijuanna-active substances. Fed. Proc. 6, 352.Google Scholar
  55. 53. Consroe, P. F., Wood, G. C. and Guchsbaum, H. (1975) Anticonvulsant nature of marijuana smoking. JAMA 234, 306-307.Google Scholar
  56. 54. Carlini, E. A. and Cunnha, J. A. (1981) Hypnotic and antiepileptic effects of cannabidiol. J. Clin. Pharmacol. 21 , 417S-427S.Google Scholar
  57. 55.
    Vachon, L., Fitzgerald, M. X., Solliday, N. H., Gould, I. A. and Gaensler, E. A. (1973) Single-dose effect of marijuana smoke: bronchial dynamics and respiratory-center sensitivity in normal subjects. N. Engl. J. Med. 288, 985 - 989.PubMedCrossRefGoogle Scholar
  58. 56.
    Williams, S. J., Hartley, J. P. R. and Graham, J. D. P. (1976) Bronchodilator effect of delta-I-tetrahydrocannabinol administered by aerosol to asthmatic patients. Thorak. 31, 720 - 723.CrossRefGoogle Scholar
  59. 57.
    Pivir, R. T., Zarcone, J., Dement, W. C. and Hollister, L. E. (1972) Delta-9-tetrahydrocannabinol and synhexyl: effects on human sleep patterns. Clin. Pharmacol. Ther. 13, 426 - 425.Google Scholar
  60. 58.
    Feinberg, I., Jones, R. and Walker, J. (1976) Effects of marijuana tetrahydrocannabinol on electroencephalographic sleep patterns. Clin. Pharmacol. Ther. 19, 782 - 794.PubMedGoogle Scholar
  61. 59.
    Anonymous Editorial. (1978) Cannabis and the cardiovascular system. Brit. Med. J. 1, 450 - 451.Google Scholar
  62. 60.
    Besusan, S. D. (1971) Marijuana withdrawal symptoms. Brit. Med. J. July: 112.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Leo E. Hollister

There are no affiliations available

Personalised recommendations